登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《JAMA，6月11日，Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-06-13

  • Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019

    A Systematic Review and Meta-analysis

    Sravanthi Parasa, MD1; Madhav Desai, MD, MPH2; Viveksandeep Thoguluva Chandrasekar, MD3; et al Harsh K. Patel, MD4; Kevin F. Kennedy, MS5; Thomas Roesch, MD6; Marco Spadaccini, MD7; Matteo Colombo, MD7; Roberto Gabbiadini, MD7; Everson L. A. Artifon, MD8; Alessandro Repici, MD7; Prateek Sharma, MD2

    Author Affiliations Article Information

    JAMA Netw Open. 2020;3(6):e2011335. doi:10.1001/jamanetworkopen.2020.11335

    Abstract

    Importance Coronavirus disease 2019 (COVID-19) is a global pandemic and can involve the gastrointestinal (GI) tract, including symptoms like diarrhea and shedding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in feces.

    Objective To provide a pooled estimate of GI symptoms, liver enzyme levels outside reference ranges, and fecal tests positive for SARS-CoV-2 among patients with COVID-19.

    Data Sources An electronic literature search was performed for published (using MEDLINE/PubMed and Embase) and preprint (using bioRxiv and medRxiv) studies of interest conducted from November 1, 2019, to March 30, 2020. Search terms included “COVID-19,” “SARS-Cov-2,” and/or “novel coronavirus.”

  • 原文来源：https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2767009?resultClick=1
38浏览量
原文链接
相关报告

  • 《JAMA，6月11日，Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-06-12
    • Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China Dong Chen, MD1,2; Xiaokun Li, MD3; Qifa Song, MD4; et al Chenchan Hu, MD1,2; Feifei Su, MD1,2; Jianyi Dai, MD1,2; Yinghai Ye, MD1,2; Jianping Huang, MD1,2; Xiaoming Zhang, MD5 Author Affiliations Article Information JAMA Netw Open. 2020;3(6):e2011122. doi:10.1001/jamanetworkopen.2020.11122 Abstract Importance Severe acute respiratory syndrome coronavirus 2 has caused a global outbreak of coronavirus disease 2019 (COVID-19). Severe acute respiratory syndrome coronavirus 2 binds angiotensin-converting enzyme 2 of the rennin-angiotensin system, resulting in hypokalemia. Objective To investigate the prevalence, causes, and clinical implications of hypokalemia, including its possible association with treatment outcomes, among patients with COVID-19. Design, Setting, and Participants This cohort study was conducted at Wenzhou Central Hospital and Sixth People’s Hospital of Wenzhou, Wenzhou, China, from January 11, 2020, to February 15, 2020. Participants included patients who received a diagnosis of COVID-19 according to the criteria issued by the Chinese Health Bureau and were admitted to the hospital. The patients were classified as having severe hypokalemia (plasma potassium <3 mmol/L), hypokalemia (plasma potassium 3-3.5 mmol/L), and normokalemia (plasma potassium >3.5 mmol/L). The clinical features, therapy, and outcomes were compared between the 3 groups. Data analysis was conducted in March 2020.
    177浏览量
    原文链接

  • 《SSRN，2月6日，Clinical Features of 2019 Novel Coronavirus Pneumonia Presented Gastrointestinal Symptoms But Without Fever Onset》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-02-07
    • Clinical Features of 2019 Novel Coronavirus Pneumonia Presented Gastrointestinal Symptoms But Without Fever Onset 19 Pages Posted: 6 Feb 2020 Ping An Wuhan University - Department of Gastroenterology Hongbin Chen Wuhan University - Department of Respiratory Medicine Abstract Background: Early detection of infected patients is one of the most important steps to mitigate spreading of 2019 novel coronavirus (2019-nCoV). Here, we report a set of atypical 2019-nCoV pneumonia cases with gastrointestinal symptoms onset but without fever or other respiratory symptoms. Methods: We retrospectively reviewed data of admitted patients of 2019-nCoV pneumonia with only digestive symptoms and no fever on the onset from January 17-24, 2019 in Renmin Hospital of Wuhan University. The patients’ history, clinical features, physical findings, complete blood count, biochemical results, chest X-ray imaging, microbiological investigation and viral pathogens results were recorded and analyzed. Findings: From January 17 to 24, 2020, nine admitted patients with only digestive symptoms and no fever on the onset had been identified as 2019-nCoV infection. None of the patients had history of contact with animals or visited to the Huanan seafood wholesale market in Wuhan, while they all had exposure history of confirmed or suspected 2019-nCoV-infected patients. Six patients had anorexia (66.7%). Other symptoms include nausea, vomit and diarrhea. All presented digestive symptoms occurred 1-3 days (median time: 2.1 days) before the patients’ visit. None of the cases had fever on onset while 5 patients occurred fever and/or respiratory symptoms 2-5 days after initial non-specific presentations. Other 4 patients never presented respiratory symptoms or fever in the following admissions. Pulmonary infiltrates including multifocal patchy ground-glass opacities were detected on CT scans in all cases at the day of their first clinic visit. All nine patients were admitted to hospital under isolation, supportive care, remained stable and none of them was transferred to ICU as of Feb 2, 2020. Interpretation: Patients with recent gastrointestinal symptoms as well as confirmed or suspected 2019-nCoV pneumonia exposure history are potential 2019-nCoV pneumonia candidates. It is significant to take atypical symptoms into account to avoid missed diagnosis, and important for gastroenterologists to strengthen protection to avoid possible infection.
    12浏览量
    原文链接